Seventure Partners is a long term equity investor that actively supports innovative companies aiming at generating positive impacts on Humankind, Society, Sustainability and the Planet.With €950m net commitments under management as of the end of 2022, Seventure is a leading venture capital firm in Europe investing since 1997 in innovative businesses with high growth potential in 2 main areas: Life sciences (Biotech, Health & digital Health, Nutrition, Foodtech, Blue Economy, Aquaculture, Animal & Agriculture, Sport & Wellness …) with a specific interest for microbiome-related innovations across Europe, Israel, Asia and North America and Digital technologies (FinTech, RetailTech etc…) in Western Europe.Investments can range between €500k and €10m per round and up to €20m per company, from early to late stage, growth, pre-IPO and IPO. Investments can range between €500k and €10m per round, or up to €20m per company, from early to late stage. Seventure is a subsidiary of Natixis Global Asset Management. Natixis is the corporate investment management and financial services arm of Groupe BPCE, the second-largest French bank.For more details: www.seventure.com

Talentsoft

Advanced Accelerator Applications

BIOMx

Expensya

Galecto

Humedics

Biophytis

TME Pharma

payleven

Push Doctor

MaaT Pharma

Mailjet

Mainstay Medical

Mauna Kea Technologies

MedinCell

Seventure Partners

Seventure Partners is a leading venture capital firm in Europe, specializing in innovative investments in digital technologies, life sciences, and sustainable development. The firm manages funds for institutional investors, family offices, and individuals, providing financing to high-growth companies across various stages of development.

FR:SEVENTURE

Seventure Partners

Filings Not Available